The estimated Net Worth of Melvin Md Sharoky is at least $3.44 Milhão dollars as of 15 May 2023. Melvin Sharoky owns over 20,000 units of Insmed Inc stock worth over $727,600 and over the last 22 years he sold INSM stock worth over $2,452,420. In addition, he makes $262,500 as Independent Director at Insmed Inc.
Melvin has made over 15 trades of the Insmed Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of INSM stock worth $385,800 on 15 May 2023.
The largest trade he's ever made was buying 88,889 units of Insmed Inc stock on 13 August 2014 worth over $1,000,001. On average, Melvin trades about 8,612 units every 127 days since 2003. As of 15 May 2023 he still owns at least 10,000 units of Insmed Inc stock.
You can see the complete history of Melvin Sharoky stock trades at the bottom of the page.
Dr. Melvin A. Sharoky M.D. serves as Independent Director of the Company. From 2007 to 2012, He is Member of Nominations and Governance Committee. he was a member of the board of directors of Par Pharmaceutical Companies, Inc. (NYSE:PRX), a publicly-traded pharmaceutical manufacturer. From 2002 to 2007, Dr. Sharoky was President and Chief Executive Officer of Somerset Pharmaceuticals, Inc. Dr. Sharoky continued as a consultant to Somerset until 2007. From 2001 to 2002, Dr. Sharoky was retired. From July 1995 to June 2001, Dr. Sharoky served as President of Somerset Pharmaceuticals. From 1995 through 1998, Dr. Sharoky was President of Watson Pharmaceuticals, Inc. (now Actavis plc), and from 1993 to 1998 he was President and Chief Executive Officer of Watson’s wholly-owned subsidiary, Circa Pharmaceuticals, Inc. From 1988 to 1993, Dr. Sharoky held various senior executive positions with Circa Pharmaceuticals. From February 1986 to June 1988, Dr. Sharoky was Vice President and Chief Medical Officer of Pharmakinetics Laboratories, Inc. Dr. Sharoky holds a Bachelor of Arts degree in biology from the University of Maryland in Baltimore County and a Doctor of Medicine degree from the University of Maryland School of Medicine. Dr. Sharoky has more than 30 years of experience in the pharmaceutical industry. The Board believes that, in addition to his medical experience as a physician, Dr. Sharoky's background as an executive of pharmaceutical companies, as well as his public company board service, brings valuable senior management, leadership, financial and strategic planning experience to our Board.
As the Independent Director of Insmed Inc, the total compensation of Melvin Sharoky at Insmed Inc is $262,500. There are 15 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.
Melvin Sharoky is 69, he's been the Independent Director of Insmed Inc since 2010. There are 1 older and 22 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Melvin's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis, eDennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: